4 August 2022 - The patient’s voice is increasingly important in securing access for therapies in markets and demonstrating how they deliver and radiate value across healthcare systems.
Conveying the nuances of patient experience as a result of their condition and the effects of therapy – and developing methodologies for assessing and rating these by appraisal authorities – is one of the greatest current challenges in pharma as missteps and misunderstandings can delay and even derail approvals.